Bacterial sepsis.
J Chemother
; 19 Suppl 2: 28-30, 2007 Oct.
Article
in En
| MEDLINE
| ID: mdl-18073176
Bacterial sepsis remain a major cause of mortality and morbidity in the newborn. The severe outcome of neonatal sepsis, despite the advances in perinatal and neonatal care and use of potent antibiotics, is related to the neonatal reduced immune defenses and the complex interactions between the infecting microorganism and the host responses. An early diagnosis, based on the clinical picture, the isolation of microorganisms and the positivity of inflammatory indexed, is mandatory. A timely treatment should be aimed to the elimination of pathogens with antimicrobials. Intravenous immunoglobulin and hematopoietic growth factors may be considered to improve the disturbed immune homeostases.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bacterial Infections
/
Sepsis
Type of study:
Diagnostic_studies
/
Screening_studies
Limits:
Humans
/
Newborn
Language:
En
Journal:
J Chemother
Journal subject:
ANTINEOPLASICOS
/
TERAPIA POR MEDICAMENTOS
Year:
2007
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom